إعلان
إعلان
ATNM
Actinium Pharmaceuticals, Inc
1.38
USDبرعاية
-0.05
-3.29%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.40
+0.02
+1.23%
تقارير أرباح ATNM
النسبة الإيجابية المفاجئة
ATNM تفوق 23 من 40 آخر التقديرات.
57%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.19
التغير الضمني من Q3 25 (Revenue/ EPS)
-100.00%
/+18.75%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-9.52%
Actinium Pharmaceuticals, Inc earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, ATNM reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 51.49% surprise. Revenue reached 90.00 ألف, compared to an expected --, with a 0.00% difference. The market reacted with a +14.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an زيادة of 18.75% EPS, and نقصان of -100.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Actinium Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Actinium Pharmaceuticals, Inc reported EPS of -$0.16, beating estimates by 51.49%, and revenue of $90.00K, 0% as expectations.
How did the market react to Actinium Pharmaceuticals, Inc's Q3 2025 earnings?
The stock price moved up 14.17%, changed from $1.27 before the earnings release to $1.45 the day after.
When is Actinium Pharmaceuticals, Inc expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Actinium Pharmaceuticals, Inc's next earnings report?
Based on 6
المحللين, Actinium Pharmaceuticals, Inc is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان